Show simple item record

dc.contributor.authorNafisi, S
dc.contributor.authorHeidari, R
dc.contributor.authorGhaffarzadeh, M
dc.contributor.authorZiaee, M
dc.contributor.authorHamzeiy, H
dc.contributor.authorGarjani, A
dc.contributor.authorEghbal, MA
dc.date.accessioned2018-08-26T08:51:20Z
dc.date.available2018-08-26T08:51:20Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53352
dc.description.abstractAcetaminophen (N-acetyl para amino phenol, APAP) is a widely used antipyretic and analgesic drug responsible for various drug-induced liver injuries. This study evaluated APAP-induced toxicity in isolated rat hepatocytes alongside the protective effects of silafibrate and N-acetyl cysteine (NAC). Hepatocytes were isolated from male Sprague-Dawley rats by collagenase enzyme perfusion via the portal vein. This technique is based on liver perfusion with collagenase after removing calcium ions (Ca2+) with a chelator. Cells were treated with different concentrations of APAP, silafibrate, and NAC. Cell death, reactive oxygen species (ROS) formation, lipid peroxidation, and mitochondrial depolarisation were measured as toxicity markers. ROS formation and lipid peroxidation occurred after APAP administration to rat hepatocytes. APAP caused mitochondrial depolarisation in isolated cells. Administration of silafibrate (200 ?mol L-1) and/or NAC (200 ?mol L-1) reduced the ROS formation, lipid peroxidation, and mitochondrial depolarisation caused by APAP. Cytotoxicity induced by APAP in rat hepatocytes was mediated by oxidative stress. In addition, APAP seemed to target cellular mitochondria during hepatocyte damage. The protective properties of silafibrate and/or NAC against APAP.induced hepatic injury may have involved the induction of antioxidant enzymes, protection against oxidative stress and inflammatory responses, and alteration in cellular glutathione content.
dc.language.isoEnglish
dc.relation.ispartofArhiv za Higijenu Rada i Toksikologiju
dc.subjectacetylcysteine
dc.subjectclofibrate derivative
dc.subjectcytoprotective agent
dc.subjectparacetamol
dc.subjectreactive oxygen metabolite
dc.subjectsilafibrate
dc.subjectunclassified drug
dc.subjectclofibrate
dc.subjectnonsteroid antiinflammatory agent
dc.subjectparacetamol
dc.subjectanimal cell
dc.subjectArticle
dc.subjectcell death
dc.subjectcell protection
dc.subjectcomparative study
dc.subjectcontrolled study
dc.subjectdrug cytotoxicity
dc.subjectgold standard
dc.subjectLC50
dc.subjectlipid peroxidation
dc.subjectliver cell
dc.subjectliver perfusion
dc.subjectmale
dc.subjectmitochondrion
dc.subjectnonhuman
dc.subjectoxidative stress
dc.subjectportal vein
dc.subjectrat
dc.subjecttoxic hepatitis
dc.subjectanalogs and derivatives
dc.subjectanimal
dc.subjectdrug effects
dc.subjectliver cell
dc.subjectpathophysiology
dc.subjectSprague Dawley rat
dc.subjecttoxic hepatitis
dc.subjectRattus
dc.subjectAcetaminophen
dc.subjectAnimals
dc.subjectAnti-Inflammatory Agents, Non-Steroidal
dc.subjectClofibrate
dc.subjectCytoprotection
dc.subjectDrug-Induced Liver Injury
dc.subjectHepatocytes
dc.subjectMale
dc.subjectRats
dc.subjectRats, Sprague-Dawley
dc.titleCytoprotective effects of silafibrate, a newly-synthesised siliconated derivative of clofibrate, against acetaminophen.induced toxicity in isolated rat hepatocytes
dc.typeArticle
dc.citation.volume65
dc.citation.issue2
dc.citation.spage169
dc.citation.epage178
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.2478/10004-1254-65-2014-2434


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record